Connection
Adit Ginde to Lopinavir
This is a "connection" page, showing publications Adit Ginde has written about Lopinavir.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.214 |
|
|
|
-
Kaizer AM, Shapiro NI, Wild J, Brown SM, Cwik BJ, Hart KW, Jones AE, Pulia MS, Self WH, Smith C, Smith SA, Ng PC, Thompson BT, Rice TW, Lindsell CJ, Ginde AA. Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial. Int J Infect Dis. 2023 Mar; 128:223-229.
Score: 0.214